LUNGevity Foundation is proud to be the largest lung cancer-focused private funder of research in the United States and is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as providing community, support, and education for all those affected by the disease. We invest in research in both early detection and targeted therapeutics.

Click here for COVID-19 Vaccine Information

Latest from Lungevity

More Than a Career: Lung Cancer Advocate Turns Passion Into Action

November 07, 2021

Upal Basu Roy has a true gift of being able to think from his heart. He educates the patient community, helps patients navigate the fragmented system, fights for drug access issues in other countries, addresses disparities and supports patient-driven initiatives in research and advocacy.

9/11 and Cancer: Health Impacts Remain 20 Years Later

September 07, 2021

Soon after the 9/11 terrorist attacks, Judy Meyers returned to work in Manhattan, despite the terrible air quality. Years later, she was diagnosed with lung cancer, which is directly related to being in New York City in the aftermath of the destruction of the Twin Towers.